In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococci.
Watanakunakorn
C
C
Department of Internal Medicine, St. Elizabeth Hospital Medical Center, Youngstown, Ohio 44501.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016983:Enterococcus / Q000187:drug effects*; D013293:Enterococcus faecalis / Q000187:drug effects; D016984:Enterococcus faecium / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D014640:Vancomycin / Q000031:analogs & derivatives / Q000494:pharmacology
D000900:Anti-Bacterial Agents; C057893:chloroorienticin A; D014640:Vancomycin